Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (21-30 of 596) with videos related to

Pageof 60
Sort By:
Best Practice & Research. Clinical Haematology|October 11, 2020
Progress in the molecular diagnostics of hematologic neoplasiaTorsten Haferlach, Jaroslaw P Maciejewski
Seminars in Oncology|February 1, 2012
Introduction: molecular pathogenesis of hematologic malignanciesJaroslaw P Maciejewski, Torsten Haferlach
Histopathology|December 16, 2024
Haematolymphoid malignancies: beyond the current classificationsDaphne de Jong, Torsten Haferlach
Haematologica|October 2, 2014
Should clinical hematologists put their microscopes on eBay?Mars van't Veer, Torsten Haferlach
Seminars in Oncology|February 1, 2012
Integration of next-generation sequencing into clinical practice: are we there yet?Alexander Kohlmann, Vera Grossmann, Torsten Haferlach
Haematologica|January 2, 2015
Answer to comment on the editorial 'Should hematologists put there microscopes on eBay?'Mars van 't Veer, Torsten Haferlach
Best Practice & Research. Clinical Haematology|October 11, 2020
WGS and WTS in leukaemia: A tool for diagnostics?Manja Meggendorfer, Wencke Walter, Torsten Haferlach
Cancer Genetics and Cytogenetics|July 5, 2005
Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disordersUlrike Bacher, Torsten Haferlach, Claudia Schoch
The New England Journal of Medicine|June 23, 2021
Genome Sequencing in Myeloid CancersTorsten Haferlach, Stephan Hutter, Manja Meggendorfer
Best Practice & Research. Clinical Haematology|February 10, 2015
Mutational profiling in patients with MDS: ready for every-day use in the clinic?Ulrike Bacher, Alexander Kohlmann, Torsten Haferlach
Pageof 60

Showing results (21-30 of 596) with videos related to

Sort By:
Pageof 60
Best Practice & Research. Clinical Haematology|October 11, 2020
Progress in the molecular diagnostics of hematologic neoplasiaTorsten Haferlach, Jaroslaw P Maciejewski
Seminars in Oncology|February 1, 2012
Introduction: molecular pathogenesis of hematologic malignanciesJaroslaw P Maciejewski, Torsten Haferlach
Histopathology|December 16, 2024
Haematolymphoid malignancies: beyond the current classificationsDaphne de Jong, Torsten Haferlach
Haematologica|October 2, 2014
Should clinical hematologists put their microscopes on eBay?Mars van't Veer, Torsten Haferlach
Seminars in Oncology|February 1, 2012
Integration of next-generation sequencing into clinical practice: are we there yet?Alexander Kohlmann, Vera Grossmann, Torsten Haferlach
Haematologica|January 2, 2015
Answer to comment on the editorial 'Should hematologists put there microscopes on eBay?'Mars van 't Veer, Torsten Haferlach
Best Practice & Research. Clinical Haematology|October 11, 2020
WGS and WTS in leukaemia: A tool for diagnostics?Manja Meggendorfer, Wencke Walter, Torsten Haferlach
Cancer Genetics and Cytogenetics|July 5, 2005
Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disordersUlrike Bacher, Torsten Haferlach, Claudia Schoch
The New England Journal of Medicine|June 23, 2021
Genome Sequencing in Myeloid CancersTorsten Haferlach, Stephan Hutter, Manja Meggendorfer
Best Practice & Research. Clinical Haematology|February 10, 2015
Mutational profiling in patients with MDS: ready for every-day use in the clinic?Ulrike Bacher, Alexander Kohlmann, Torsten Haferlach
Pageof 60